ITEM#: 3042-159845020MG
MFR#: 1598450-20MG
Ranitidine Resolution Mixture United States Pharmacopeia (USP) Reference Standard
Product Name | Description | Item# | QTY | |
---|---|---|---|---|
Dalfampridine Resolution Mixture | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-116244315MG | EA | |
Zanamivir Resolution Mixture | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-1724066025MG | EA | |
Naratriptan Resolution Mixture | Naratriptan Resolution Mixture United States Pharmacopeia (USP) Reference Standard | 3042-145749120MG | EA | |
Mirtazapine resolution mixture | Mirtazapine resolution mixture United States Pharmacopeia (USP) Reference Standard | 3042-144429625MG | EA | |
Paliperidone Resolution Mixture | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issui | 3042-149179520MG | EA | |
Lamivudine Resolution Mixture A | Lamivudine Resolution Mixture A United States Pharmacopeia (USP) Reference Standard | 3042-135684710MG | EA | |
Dutasteride Resolution Mixture | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-122993120MG | EA | |
Cyclosporine Resolution Mixture | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-115865025MG | EA | |
Valrubicin Resolution Mixture | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-170875125MG | EA |
Thank you for visiting, your account is pending approval.
You will received email notification for approval within 24hrs.
Contact customerservice@franklinyoung.com for any questions.
Thank you for requesting an account with Franklin Young.
Your request has been declined
We restrict website access to government entities, and related customers.
Please contact customerservice@franklinyoung.com with any questions.